Prosecution Insights
Last updated: August 17, 2026

Examiner: BARRON, SEAN C

Tech Center 1700 • Art Units: 1637 1653 1682 1798

This examiner grants 53% of resolved cases

Performance Statistics

53.3%
Allow Rate
-11.7% vs TC avg
700
Total Applications
+30.6%
Interview Lift
1319
Avg Prosecution Days
Based on 612 resolved cases, 2023–2026

Rejection Statute Breakdown

7.0%
§101 Eligibility
14.0%
§102 Novelty
45.0%
§103 Obviousness
24.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18687661 METHODS AND COMPOSITIONS FOR INDUCING FETAL HEMOGLOBIN, MODULATING ERYTHROID CELL LINEAGES, AND PERTURBING MEGAKARYOCYTE LINEAGES Non-Final OA FLAGSHIP PIONEERING INNOVATIONS VI, LLC
18705735 HYDROGEL STRUCTURES AND METHODS OF MAKING AND USE THEREOF Non-Final OA GEORGIA TECH RESEARCH CORPORATION
18580417 Methods and Model Systems for Assessing Therapeutic Properties of Candidate Agents and Related Computer Readable Media and Systems Non-Final OA The Regents of the University of California
18255307 AMNIOTIC MEMBRANE FOR MYOCARDIAL REPAIR Non-Final OA The Regents of the University of California
18315370 MICROFLUDIC LAB-ON-CHIP DEVICE, MATRIX, SMALL MOLECULES AND THREE-DIMENSIONAL SPHEROIDS FOR CELL REPROGRAMMING Non-Final OA The Regents of the University of California
17778393 CULTURES OF AND METHODS OF MANUFACTURING SQUAMOUS CELL CARCINOMA CELLS Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
16772865 A METHOD FOR STABILIZING CELL CULTURE SYSTEMS USING AN AMPHIPHILIC GRAFT COPOLYMER AS CELL CULTURE REAGENT Non-Final OA BASF SE
18561236 MULTI-REGIONAL HUMAN NEURAL CIRCUITS IN ASSEMBLOIDS DERIVED FROM PLURIPOTENT STEM CELLS Final Rejection The Board of Trustees of the Leland Stanford Junior University
16634076 METHOD FOR ISOLATING EXTRACELLULAR VESICLE USING HYDROPHOBIC INTERACTION Final Rejection POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION
18575437 FLUID SHEAR STRESS FOR EX VIVO ACTIVATION OF IMMUNE EFFECTOR CELLS Non-Final OA Vanderbilt University
18293040 ENGINEERING AAV VECTORS WITH IMPROVED CNS TARGETING Non-Final OA University of Florida Research Foundation, Incorporated
18063001 Engineered 3D-Printed Artificial Axons Final Rejection Massachusetts Institute of Technology
17440618 CONTROL OF NITROGEN FIXATION IN RHIZOBIA THAT ASSOCIATE WITH CEREALS Final Rejection Massachusetts Institute of Technology
18437974 PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ISCHEMIC CEREBROVASCULAR DISEASE Non-Final OA Research & Business Foundation Sungkyunkwan University
18568589 PRE-EPICARDIAL CELLS AND USES THEREOF Non-Final OA The General Hospital Corporation
17781279 Nerve Xenografts and Related Methods Non-Final OA The General Hospital Corporation
17394008 MESENCHYMAL CELL-DERIVED EXOSOMES TO TREAT NEUROLOGICAL DISORDERS Final Rejection RAMOT AT TEL-AVIV UNIVERSITY LTD.
18687608 COMPOSITIONS AND METHODS FOR CELL REPROGRAMMING Non-Final OA CORNELL UNIVERSITY
17761879 Cell Culture Media Tablets and Methods of Manufacture Non-Final OA LIFE TECHNOLOGIES CORPORATION
17776164 MATRICES FOR CELL CULTURE Final Rejection AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month